APA (7th ed.) Citation

Zhao, Y., Li, L., Jiang, Y., Sun, Y., Xu, Y., Ye, X., . . . Ma, S. (2025). PIK75 effectively reverses PI3K‒AKT activation caused by palbociclib resistance and synergistically inhibits the progression of esophageal squamous cell carcinoma. Scientific Reports, 15(1), 1. https://doi.org/10.1038/s41598-025-26858-5

Chicago Style (17th ed.) Citation

Zhao, Yaning, et al. "PIK75 Effectively Reverses PI3K‒AKT Activation Caused by Palbociclib Resistance and Synergistically Inhibits the Progression of Esophageal Squamous Cell Carcinoma." Scientific Reports 15, no. 1 (2025): 1. https://doi.org/10.1038/s41598-025-26858-5.

MLA (9th ed.) Citation

Zhao, Yaning, et al. "PIK75 Effectively Reverses PI3K‒AKT Activation Caused by Palbociclib Resistance and Synergistically Inhibits the Progression of Esophageal Squamous Cell Carcinoma." Scientific Reports, vol. 15, no. 1, 2025, p. 1, https://doi.org/10.1038/s41598-025-26858-5.